UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trends of prevalence of primary HIV drug resistance in Germany

Journal of antimicrobial chemotherapy, 2007-10, Vol.60 (4), p.843-848

2007

Volltextzugriff (PDF)

Does Sofosbuvir (SOF)/Velpatasvir (VEL) with or without Ribavirin (RBV) change the landscape of therapy in chronic hepatitis C genotype 3 (GT 3) infection? – Results from the GErman hepatitis C COhort (GECCO)

Journal of hepatology, 2017, Vol.66 (1), p.S739-S739

2017

Volltextzugriff (PDF)

Treatment of Patients with Hepatitis C Virus (HCV) Genotype 3 Infection in the Era of Direct Acting Antivirals (DAA): Data from the German Hepatitis C-Registry (DHC-R)

Journal of hepatology, 2016, Vol.64 (2), p.S794-S794

2016

Volltextzugriff (PDF)

Relapse and Treatment-Emergent RAVS with DAA-Based Regimens in Hepatitis C Virus (HCV) Mono- or Human Immunodeficiency Virus (HIV)-HCV Co-Infected Patients – a Real Concern in Clinical Practice? Results from the German Hepatitis C Cohort (GECCO)

Journal of hepatology, 2016, Vol.64 (2), p.S821-S821

2016

Volltextzugriff (PDF)

P0835 : German multicenter cohort on sofosbuvir-based treatments in HCV mono- and HIV/HCV co-infected patients (GECOSO)

Journal of hepatology, 2015-04, Vol.62, p.S650-S650

2015

Volltextzugriff (PDF)

727 EFFECT OF HBV THERAPY ON RENAL FUNCTION IN PATIENTS WITH CHRONIC HEPATITIS B

Journal of hepatology, 2010, Vol.52, p.S283-S283

2010

Volltextzugriff (PDF)

Small bowel obstruction: role and contribution of sonography

European radiology, 1997-01, Vol.7 (7), p.1054-1058

1997

Volltextzugriff (PDF)

Imaging in infections of the left iliac fossa

Diagnostic and interventional imaging, 2012-06, Vol.93 (6), p.466-472

2012

Volltextzugriff (PDF)

Lipoprotein(a) in patients initiating antiretroviral therapy

HIV medicine, 2008-07, Vol.9 (6), p.415-420

2008

Volltextzugriff (PDF)

A prospective controlled study of interferon‐based therapy of chronic hepatitis C in patients on methadone maintenance

Hepatology (Baltimore, Md.), 2004-07, Vol.40 (1), p.120-124

2004

Volltextzugriff (PDF)

Antiretroviral therapy with tenofovir is associated with mild renal dysfunction

AIDS (London), 2005-01, Vol.19 (1), p.93-95

2005

Volltextzugriff (PDF)

Behandlung der chronischen Hepatitis-C-Virusinfektion vom Genotyp 3 mit direkt antiviralen Substanzen: Daten aus dem Deutschen Hepatitis C-Register (DHC-R)

Zeitschrift für Gastroenterologie, 2016, Vol.54 (8)

2016

Volltextzugriff (PDF)

Significant changes of HCV patient characteristics over time in the era of direct antiviral agent therapy – are all HCV subpopulations treated similarly? – Results from the German hepatitis C Cohort

Journal of hepatology, 2018-04, Vol.68, p.S289-S290

2018

Volltextzugriff (PDF)

THU-358 - Significant changes of HCV patient characteristics over time in the era of direct antiviral agent therapy – are all HCV subpopulations treated similarly? – Results from the German hepatitis C Cohort

Journal of hepatology, 2018-04, Vol.68, p.S289-S290

2018

Volltextzugriff (PDF)

Efficacy of third-line therapy using bevacizumab in a patient with metastatic colorectal cancer

Current oncology (Toronto), 2009-09, Vol.16 (5), p.84-86

2009

Volltextzugriff (PDF)

SAT-275 - Does Sofosbuvir (SOF)/Velpatasvir (VEL) with or without Ribavirin (RBV) change the landscape of therapy in chronic hepatitis C genotype 3 (GT 3) infection? – Results from the GErman hepatitis C COhort (GECCO)

Journal of hepatology, 2017, Vol.66 (1), p.S739-S739

2017

Volltextzugriff (PDF)

L‐Carnitine in the treatment of HIV‐associated lipodystrophy syndrome

HIV medicine, 2001-01, Vol.2 (1), p.59-60

2001

Volltextzugriff (PDF)

Mitochondrial DNA depletion in liver tissue of patients infected with hepatitis C virus: contributing effect of HIV infection?

HIV medicine, 2005-03, Vol.6 (2), p.135-139

2005

Volltextzugriff (PDF)

SAT-265 - Relapse and Treatment-Emergent RAVS with DAA-Based Regimens in Hepatitis C Virus (HCV) Mono- or Human Immunodeficiency Virus (HIV)-HCV Co-Infected Patients – a Real Concern in Clinical Practice? Results from the German Hepatitis C Cohort (GECCO)

Journal of hepatology, 2016, Vol.64 (2), p.S821-S821

2016

Volltextzugriff (PDF)

Atypical pattern of acute severe shoulder pain: contribution of sonography

Joint, bone, spine : revue du rhumatisme, 2004-11, Vol.71 (6), p.592-594

2004

Volltextzugriff (PDF)

Prediction of Complicated Clostridium difficile Infection by Pleural Effusion and Increased Wall Thickness on Computed Tomography

Clinical infectious diseases, 2009-08, Vol.49 (4), p.554-560

2009

Volltextzugriff (PDF)

SAT-208 - Treatment of Patients with Hepatitis C Virus (HCV) Genotype 3 Infection in the Era of Direct Acting Antivirals (DAA): Data from the German Hepatitis C-Registry (DHC-R)

Journal of hepatology, 2016, Vol.64 (2), p.S794-S794

2016

Volltextzugriff (PDF)

Safety, efficacy and development of resistance under the new protease inhibitor lopinavir/ritonavir: 48-week results

Infection, 2004-04, Vol.32 (2), p.82-88

2004

Volltextzugriff (PDF)

A prospective, controlled study assessing the effect of lopinavir on amprenavir concentrations boosted by ritonavir

HIV medicine, 2004-01, Vol.5 (1), p.15-17

2004

Volltextzugriff (PDF)

Simultaneous determination of the new HIV protease inhibitor lopinavir (ABT 378) and of indinavir(1), amprenavir, saquinavir, ritonavir (ABT 538)(2) and nelfinavir(3) in human plasma by gradient HPLC

Clinical laboratory (Heidelberg), 2001, Vol.47 (9-10), p.471

2001

Volltextzugriff (PDF)

1 – 25 von 844

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(659)
Mit Volltextzugriff
(590)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(388)
Life Sciences & Biomedicine
(258)
Humans
(206)
Male
(122)
Female
(121)
Physical Sciences
(105)
Animals
(87)
Adult
(70)
Middle Aged
(67)
Biological And Medical Sciences
(66)
Sciences Biologiques Et Medicales
(61)
Sciences Medicales
(61)
Genetics & Heredity
(48)
Life Sciences
(48)
Aged
(47)
Agriculture
(41)
Astronomy & Astrophysics
(41)
Fundamental And Applied Biological Sciences. Psychology
(37)
Genomes
(37)
Technology
(36)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Trends of prevalence of primary HIV drug resistance in Germany

Does Sofosbuvir (SOF)/Velpatasvir (VEL) with or without Ribavirin (RBV) change the landscape of therapy in chronic hepatitis C genotype 3 (GT 3) infection? – Results from the GErman hepatitis C COhort (GECCO)

Treatment of Patients with Hepatitis C Virus (HCV) Genotype 3 Infection in the Era of Direct Acting Antivirals (DAA): Data from the German Hepatitis C-Registry (DHC-R)

Relapse and Treatment-Emergent RAVS with DAA-Based Regimens in Hepatitis C Virus (HCV) Mono- or Human Immunodeficiency Virus (HIV)-HCV Co-Infected Patients – a Real Concern in Clinical Practice? Results from the German Hepatitis C Cohort (GECCO)

P0835 : German multicenter cohort on sofosbuvir-based treatments in HCV mono- and HIV/HCV co-infected patients (GECOSO)

727 EFFECT OF HBV THERAPY ON RENAL FUNCTION IN PATIENTS WITH CHRONIC HEPATITIS B

Small bowel obstruction: role and contribution of sonography

Imaging in infections of the left iliac fossa

Lipoprotein(a) in patients initiating antiretroviral therapy

A prospective controlled study of interferon‐based therapy of chronic hepatitis C in patients on methadone maintenance

Antiretroviral therapy with tenofovir is associated with mild renal dysfunction

Behandlung der chronischen Hepatitis-C-Virusinfektion vom Genotyp 3 mit direkt antiviralen Substanzen: Daten aus dem Deutschen Hepatitis C-Register (DHC-R)

Significant changes of HCV patient characteristics over time in the era of direct antiviral agent therapy – are all HCV subpopulations treated similarly? – Results from the German hepatitis C Cohort

THU-358 - Significant changes of HCV patient characteristics over time in the era of direct antiviral agent therapy – are all HCV subpopulations treated similarly? – Results from the German hepatitis C Cohort

Efficacy of third-line therapy using bevacizumab in a patient with metastatic colorectal cancer

SAT-275 - Does Sofosbuvir (SOF)/Velpatasvir (VEL) with or without Ribavirin (RBV) change the landscape of therapy in chronic hepatitis C genotype 3 (GT 3) infection? – Results from the GErman hepatitis C COhort (GECCO)

L‐Carnitine in the treatment of HIV‐associated lipodystrophy syndrome

Mitochondrial DNA depletion in liver tissue of patients infected with hepatitis C virus: contributing effect of HIV infection?

SAT-265 - Relapse and Treatment-Emergent RAVS with DAA-Based Regimens in Hepatitis C Virus (HCV) Mono- or Human Immunodeficiency Virus (HIV)-HCV Co-Infected Patients – a Real Concern in Clinical Practice? Results from the German Hepatitis C Cohort (GECCO)

Atypical pattern of acute severe shoulder pain: contribution of sonography

Prediction of Complicated Clostridium difficile Infection by Pleural Effusion and Increased Wall Thickness on Computed Tomography

SAT-208 - Treatment of Patients with Hepatitis C Virus (HCV) Genotype 3 Infection in the Era of Direct Acting Antivirals (DAA): Data from the German Hepatitis C-Registry (DHC-R)

Safety, efficacy and development of resistance under the new protease inhibitor lopinavir/ritonavir: 48-week results

A prospective, controlled study assessing the effect of lopinavir on amprenavir concentrations boosted by ritonavir

Simultaneous determination of the new HIV protease inhibitor lopinavir (ABT 378) and of indinavir(1), amprenavir, saquinavir, ritonavir (ABT 538)(2) and nelfinavir(3) in human plasma by gradient HPLC

Suchergebnisse filtern